Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

Paolo A. Ascierto, Grant A. McArthur, Brigitte Dréno, Victoria Atkinson, Gabrielle Liszkay, Anna Maria Di Giacomo, Mario Mandalà, Lev Demidov, Daniil Stroyakovskiy, Luc Thomas, Luis de la Cruz-Merino, Caroline Dutriaux, Claus Garbe, Yibing Yan, Matthew Wongchenko, Ilsung Chang, Jessie J. Hsu, Daniel O. Koralek, Isabelle Rooney, Antoni RibasJames Larkin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cobimetinib combined with vemurafenib in advanced BRAF<sup>V600</sup>-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences